Overview

Sex Differences in Neural Response to Cannabidiol

Status:
Not yet recruiting

Trial end date:
2023-02-28

Target enrollment:

Participant gender:

Summary

This is a randomized, double-blind, within-subjects, cross-over design to assess neural changes following a single dose of cannabidiol (CBD) (600mg) versus placebo among healthy female volunteers.

Phase:

Early Phase 1

Details

Lead Sponsor:

Yale University

Treatments:

Cannabidiol
Epidiolex